WINT logo

Windtree Therapeutics (WINT) Accounts Payable

Annual Accounts Payable

$809.00 K
+$560.00 K+224.90%

31 December 2023

WINT Accounts Payable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Accounts Payable

$2.97 M
+$1.28 M+75.78%

30 June 2024

WINT Quarterly Accounts Payable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

WINT Accounts Payable Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+224.9%+214.5%
3 y3 years-30.3%+410.1%
5 y5 years-76.3%+389.1%

WINT Accounts Payable High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-30.3%+224.9%at high+1092.4%
5 y5 years-76.3%+224.9%at high+1092.4%
alltimeall time-89.8%+709.0%-63.6%+2869.0%

Windtree Therapeutics Accounts Payable History

DateAnnualQuarterly
June 2024
-
$2.97 M(+75.8%)
Mar 2024
-
$1.69 M(+108.8%)
Dec 2023
$809.00 K(+224.9%)
$809.00 K(-14.3%)
Sept 2023
-
$944.00 K(-2.1%)
June 2023
-
$964.00 K(+28.0%)
Mar 2023
-
$753.00 K(+202.4%)
Dec 2022
$249.00 K(-64.1%)
$249.00 K(-39.3%)
Sept 2022
-
$410.00 K(-61.8%)
June 2022
-
$1.07 M(+48.1%)
Mar 2022
-
$724.00 K(+4.5%)
Dec 2021
$693.00 K(-40.3%)
$693.00 K(+19.1%)
Sept 2021
-
$582.00 K(+102.1%)
June 2021
-
$288.00 K(-69.3%)
Mar 2021
-
$939.00 K(-19.1%)
Dec 2020
$1.16 M(-32.0%)
$1.16 M(+59.9%)
Sept 2020
-
$726.00 K(-40.6%)
June 2020
-
$1.22 M(-12.7%)
Mar 2020
-
$1.40 M(-18.0%)
Dec 2019
$1.71 M(-50.1%)
$1.71 M(+181.4%)
Sept 2019
-
$607.00 K(-16.2%)
June 2019
-
$724.00 K(-48.9%)
Mar 2019
-
$1.42 M(-58.6%)
Dec 2018
$3.42 M(+47.2%)
$3.42 M(-24.3%)
Sept 2018
-
$4.52 M(+6.1%)
June 2018
-
$4.26 M(-9.1%)
Mar 2018
-
$4.68 M(+101.5%)
Dec 2017
$2.32 M(+28.2%)
$2.32 M(-38.4%)
Sept 2017
-
$3.77 M(+32.5%)
June 2017
-
$2.85 M(+23.1%)
Mar 2017
-
$2.31 M(+27.5%)
Dec 2016
$1.81 M(+391.3%)
$1.81 M(-65.4%)
Sept 2016
-
$5.24 M(-32.1%)
June 2016
-
$7.71 M(+39.9%)
Mar 2016
-
$5.51 M(+1393.8%)
Dec 2015
$369.00 K(+5.4%)
$369.00 K(-85.0%)
Sept 2015
-
$2.46 M(+6.2%)
June 2015
-
$2.31 M(+229.6%)
Mar 2015
-
$702.00 K(+100.6%)
Dec 2014
$350.00 K(-75.6%)
$350.00 K(-75.1%)
Sept 2014
-
$1.40 M(-6.9%)
June 2014
-
$1.51 M(-41.5%)
Mar 2014
-
$2.58 M(+79.9%)
Dec 2013
$1.43 M(+22.9%)
$1.43 M(-3.8%)
Sept 2013
-
$1.49 M(-22.4%)
June 2013
-
$1.92 M(+5.2%)
Mar 2013
-
$1.82 M(+56.5%)
Dec 2012
$1.17 M(+5.0%)
$1.17 M(+460.6%)
Sept 2012
-
$208.00 K(-84.4%)
June 2012
-
$1.33 M(-0.3%)
Mar 2012
-
$1.34 M(+20.5%)
Dec 2011
$1.11 M(-34.1%)
$1.11 M(-19.8%)
Sept 2011
-
$1.39 M(-30.2%)
June 2011
-
$1.99 M(+6.0%)
Mar 2011
-
$1.87 M(+11.2%)
Dec 2010
$1.69 M(+30.2%)
$1.69 M(+6.6%)
Sept 2010
-
$1.58 M(+27.9%)
June 2010
-
$1.24 M(+7.7%)
Mar 2010
-
$1.15 M(-11.4%)
DateAnnualQuarterly
Dec 2009
$1.29 M(-38.7%)
$1.29 M(-17.0%)
Sept 2009
-
$1.56 M(-15.7%)
June 2009
-
$1.85 M(-1.6%)
Mar 2009
-
$1.88 M(-10.9%)
Dec 2008
$2.11 M(+178.5%)
$2.11 M(-13.1%)
Sept 2008
-
$2.43 M(-19.1%)
June 2008
-
$3.00 M(+55.7%)
Mar 2008
-
$1.93 M(+154.2%)
Dec 2007
$758.00 K(-53.5%)
$758.00 K(-88.9%)
Sept 2007
-
$6.82 M(+10.3%)
June 2007
-
$6.18 M(+20.8%)
Mar 2007
-
$5.12 M(+214.2%)
Dec 2006
$1.63 M(-78.4%)
$1.63 M(-76.3%)
Sept 2006
-
$6.87 M(-4.7%)
June 2006
-
$7.20 M(-11.8%)
Mar 2006
-
$8.17 M(+8.3%)
Dec 2005
$7.54 M(-5.4%)
$7.54 M(+9.8%)
Sept 2005
-
$6.87 M(+1.5%)
June 2005
-
$6.77 M(+9.3%)
Mar 2005
-
$6.19 M(-22.3%)
Dec 2004
$7.97 M(+89.3%)
$7.97 M(+88.9%)
Sept 2004
-
$4.22 M(-9.3%)
June 2004
-
$4.65 M(+6.6%)
Mar 2004
-
$4.36 M(+3.6%)
Dec 2003
$4.21 M(+39.7%)
$4.21 M(+15.7%)
Sept 2003
-
$3.64 M(+35.1%)
June 2003
-
$2.69 M(+4.9%)
Mar 2003
-
$2.57 M(-14.8%)
Dec 2002
$3.01 M(+72.2%)
$3.01 M(+50.6%)
Sept 2002
-
$2.00 M(+19.8%)
June 2002
-
$1.67 M(+13.2%)
Mar 2002
-
$1.48 M(-15.7%)
Dec 2001
$1.75 M(-26.5%)
$1.75 M(+109.3%)
Sept 2001
-
$836.00 K(-22.0%)
June 2001
-
$1.07 M(-36.5%)
Mar 2001
-
$1.69 M(-29.1%)
Dec 2000
$2.38 M(+460.5%)
$2.38 M(+142.8%)
Sept 2000
-
$981.00 K(+44.7%)
June 2000
-
$678.00 K(-2.3%)
Mar 2000
-
$694.00 K(+63.3%)
Dec 1999
$425.00 K(-61.4%)
$425.00 K(-15.0%)
Sept 1999
-
$500.00 K(-54.5%)
June 1999
-
$1.10 M(-15.4%)
Mar 1999
-
$1.30 M(+18.2%)
Dec 1998
$1.10 M(+83.3%)
$1.10 M(+22.2%)
Sept 1998
-
$900.00 K(0.0%)
June 1998
-
$900.00 K(+12.5%)
Mar 1998
-
$800.00 K(+33.3%)
Dec 1997
$600.00 K(+500.0%)
$600.00 K(+200.0%)
Sept 1997
-
$200.00 K(+100.0%)
June 1997
-
$100.00 K(-50.0%)
Mar 1997
-
$200.00 K(+100.0%)
Dec 1996
$100.00 K(0.0%)
$100.00 K(0.0%)
Sept 1996
-
$100.00 K(0.0%)
June 1996
-
$100.00 K(0.0%)
Mar 1996
-
$100.00 K(0.0%)
Dec 1995
$100.00 K
$100.00 K(-50.0%)
June 1995
-
$200.00 K(+100.0%)
Mar 1995
-
$100.00 K

FAQ

  • What is Windtree Therapeutics annual accounts payable?
  • What is the all time high annual accounts payable for Windtree Therapeutics?
  • What is Windtree Therapeutics annual accounts payable year-on-year change?
  • What is Windtree Therapeutics quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Windtree Therapeutics?
  • What is Windtree Therapeutics quarterly accounts payable year-on-year change?

What is Windtree Therapeutics annual accounts payable?

The current annual accounts payable of WINT is $809.00 K

What is the all time high annual accounts payable for Windtree Therapeutics?

Windtree Therapeutics all-time high annual accounts payable is $7.97 M

What is Windtree Therapeutics annual accounts payable year-on-year change?

Over the past year, WINT annual accounts payable has changed by +$560.00 K (+224.90%)

What is Windtree Therapeutics quarterly accounts payable?

The current quarterly accounts payable of WINT is $2.97 M

What is the all time high quarterly accounts payable for Windtree Therapeutics?

Windtree Therapeutics all-time high quarterly accounts payable is $8.17 M

What is Windtree Therapeutics quarterly accounts payable year-on-year change?

Over the past year, WINT quarterly accounts payable has changed by +$2.02 M (+214.51%)